VECTURA GROUP PLC
Exhibitor at CPhI Worldwide 2021
integrates formulation, device and development capabilities to offer a broad
range of services to help customers bring inhaled medicines to market.
Vectura offers comprehensive services from the pre-clinical stage of development, when customers are looking to overcome complex inhaled formulation challenges, select a delivery device and move quickly to the clinic. With expertise in powder and liquid formulations, as well as a portfolio of proprietary device and formulation technologies, Vectura can help customers developing a wide range of small molecules, biologics and complex combinations.
Optimising drug formulation and delivery device development can unlock the potential for innovative inhaled medicines that can revolutionise patients’ lives. Vectura is at the forefront of integrated drug and device development, and helping customers to deliver the inhaled therapies of the future.
Specs about this supplier
|Sales markets||Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)|
|Affiliated categories:||Analytical Chemistry |Analytical Development |Analytical Methods More|
Products featured at CPhI Worldwide 2021
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation